T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Findings suggest targeting neuro-immune pathway could lead to strategies for managing diabetes, obesity or some types of ...

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

The system features a cutting-edge end-effector equipped ... and an S-Beam load cell to ensure precise handling and weighing ...

For the treatment of HBV, the Company aims to achieve sustained loss of circulating viral antigens and markers of viral replication after stopping ... KIMMTRAK is a novel bispecific protein comprised ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

The human immune system is a complex network of cells and signals that guards against disease, yet in the case of cancer, it ...

T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), a type of white blood cell. T lymphocytes (T cells) and B lymphocytes (B cells) are two types of white blood ...

Ovarian tumors are infiltrated by both effector (CD4+CD25-) T cells and by an excess of TREG cells (CD4+CD25+). These TREG cells impede the function of the effectors in combating the tumor.

To avoid diseases, specific resistance (R) genes are employed to directly or indirectly recognize effectors translocated into host cells. Recognition of such avirulence (Avr) effectors often results ...

It can feel a little overwhelming, even though they're often slow or difficult to unlock and discover. That's where a Dead Cells weapons tier list comes in. While we haven't gone into detail about ...